Stanford Finds Immune Switch That Slows Aging in Mice

Scientists may have found a master switch for aging, and it lives inside immune cells that forget how to take out the trash.

Researchers at Stanford Medicine discovered that as we age, certain immune cells called tissue-resident macrophages lose their ability to clear away damaged cells that promote inflammation. These cleanup crews live permanently in our organs, but over time they stop doing their job effectively.

The team identified a specific receptor on these macrophages that responds to inflammatory hormones. When they blocked this single receptor in mice, something remarkable happened across the entire body.

The treated mice maintained youthful characteristics in their brains, hearts, muscles, liver, spleen, bone marrow, kidneys, and colons. They stayed leaner and stronger. Their memory remained sharp. They avoided frailty, excess fat, and heart problems that typically come with aging.

The culprit is a receptor called EP2, which responds to PGE2, a hormone involved in inflammation and pain. As animals age, PGE2 production increases, and the EP2 receptors on macrophages become overactive. This prevents the macrophages from swallowing up senescent neutrophils, damaged immune cells that release harmful chemicals and damage surrounding tissue.

About 100 billion neutrophils are produced every day, and roughly 90% of them need to be cleared away within 12 to 24 hours. When this cleanup fails, senescent neutrophils accumulate and spread inflammation throughout the body.

Dr. Katrin Andreasson, the Edward F. and Irene Thiel Pimley Professor in Neurology at Stanford, led the research published in Science. "We've been trying to figure out why we age," she said. "Now we know at least one big reason for it."

The findings work in human cells too. The research team confirmed that the same receptor exists in human tissue-resident macrophages and responds to the same inflammatory signals.

The Ripple Effect

This discovery goes beyond understanding aging. It points toward actual treatments that could help people stay healthy longer. The receptor can be targeted with drugs, potentially slowing age-related deterioration across multiple organ systems at once.

The research also validates what scientists have long suspected: chronic, body-wide inflammation plays a central role in aging and its associated health problems. By restoring the immune system's ability to clear away inflammatory cells, we might be able to address aging at its source rather than treating individual age-related diseases one by one.

The next step is developing safe compounds that can block this receptor in humans without disrupting other important immune functions. If successful, such treatments could extend not just lifespan, but the number of years people remain genuinely healthy and active.

For now, this mouse study offers something equally valuable: hope that aging isn't an unstoppable force, but a process we might learn to slow down.